Form D · Biotechnology

Symic Holdings, LLC

Emeryville, CA · CIK 0001626358

Offering snapshot reported May 26, 2017 · SEC filing

Reported sold
$29.4M
Offering amount: $29.4M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 20, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 26, 2017Initial$29,436,399No comparison18SEC filing
Dec 7, 2015Initial$25,275,417No comparison23SEC filing
Aug 7, 2015Amendment$17,670,955$8,780,448vs Jan 8, 201542SEC filing
Jan 8, 2015Initial$8,890,507No comparison42SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-287542

Source: Form D, filed May 26, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Claus Christiansen Director
Kenneth N. Horne Director, Executive
Jocelyn Jackson Executive
Scott Morrison Director
Bill Newell Director
William Newell Director
Armen B. Shanafelt Director
Barbara Yanni Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5980 Horton Street, Suite 600
Emeryville, CA, 94608